+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization



Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization



Journal of Neurochemistry 62(2): 549-556



The cocaine analogue RTI-55 was evaluated as a probe for in vitro labeling and localization of dopamine and serotonin transporters after death in the human brain. Kinetic, saturation, and competition binding experiments indicated complex interactions of the radioligand with the identification of multiple recognition sites. In membrane binding assays, the association of [125I]RTI-55 at 25 degrees C to putamen membranes was monophasic. In contrast, dissociation of [125I]RTI-55 occurred in two phases with t1/2 values of 9.4 and 36.5 min, respectively. Saturation analysis of [125I]RTI-55 binding demonstrated two binding sites in the human putamen with KD values of 0.10 +/- 0.02 and 1.81 +/- 0.46 nM. The binding of [125I]RTI-55 was displaced by a wide range of cocaine analogues and monoamine uptake inhibitors. The rank order of potency demonstrated in competition assays with human putamen membranes indicates that the radioligand labels cocaine recognition sites on the dopamine transporter (mazindol > GBR 12909 > GBR 12935 > paroxetine > nisoxetine > desipramine > or = fluoxetine > citalopram). In the human occipital cortex, [125I]RTI-55 recognized multiple binding sites with KD values of 0.02 +/- 0.01 and 4.18 +/- 0.46 nM. The rank order of potency for inhibition of [125I]RTI-55 binding to cerebral cortex membranes (paroxetine > citalopram > GBR 12909 > or = mazindol > or = nisoxetine > benztropine) suggests that [125I]RTI-55 labels the serotonin transporter in the human occipital cortex. Autoradiographic mapping of [125I]RTI-55 revealed very high densities of cocaine recognition sites over areas known to be rich in dopaminergic innervation, including the caudate, putamen, and nucleus accumbens.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 047940577

Download citation: RISBibTeXText

PMID: 8294917

DOI: 10.1046/j.1471-4159.1994.62020549.x


Related references

High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12(1): 27-36, 1992

Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors. Nuclear Medicine and Biology 24(5): 389-393, 1997

Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121. Synapse 21(4): 364-372, 1995

Mapping dopamine transporters in the human brain with novel selective cocaine analog (125I)RTI-121. Synapse (New York) 21(4): 364-372, 1995

Selective in vitro and in vivo binding of (125I)ADAM to serotonin transporters in rat brain. Synapse (New York) 38(4): 403-412, 2000

Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding. Molecular Pharmacology 43(2): 264-270, 1993

In vitro autoradiographic characterization of 3 beta 4 iodophenyltropane 2 beta carboxylic acid methyl iodine 125 rii 55 binding to dopamine and serotonin uptake site in rat brain. Society for Neuroscience Abstracts 17(1-2): 155, 1991

Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate. Journal of Pharmacology and Experimental Therapeutics 274(1): 385-395, 1995

Dopamine and serotonin release in vitro induced by electrical stimulation in A-9 and A-10 dopamine regions of rat brain Characterization and responsiveness to cocaine. Journal of Pharmacology & Experimental Therapeutics 267(1): 379-389, 1993

3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine. Journal of Pharmacology and Experimental Therapeutics 267(1): 379-389, 1993

4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl- piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies. Journal of Pharmacology and Experimental Therapeutics 272(1): 429-437, 1995

3-Aryl-2-(3'-substituted-1',2',4'-oxadiazol-5'-yl)tropane analogues of cocaine: affinities at the cocaine binding site at the dopamine, serotonin, and norepinephrine transporters. Journal of Medicinal Chemistry 36(20): 2886-2890, 1993

Ontogeny of the dopamine and serotonin transporters in the rat brain: an autoradiographic study. Neuroscience Letters 363(3): 266-271, 2004

Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. Journal of Pharmacology and Experimental Therapeutics 255(2): 843-857, 1990

Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate. Synapse 28(4): 322-338, 1998